Gene · 3192
NIH grants1,645
NIH grants whose papers are about the gene, through NIH's grant-paper links.
121 to 140 of 1,645
Download this page as JSON| Grant | Title | HNRNPU papers | Newest fiscal year |
|---|---|---|---|
| R01AG067763 | Molecular characterization of extracellular vesicles for the spread of misfolded tau protein | 1 | 2025 |
| R01AG071869 | Defining the programmed proteome rejuvenation underlying gametogenesis | 1 | 2025 |
| R01AG074012 | Systems Genetics Analysis of Sex Differences in Alzheimer's Disease | 1 | 2025 |
| R01AG078307 | PHD2 mediated loss of hypoxia signaling limits skeletal muscle regeneration and exercise response in aging | 1 | 2025 |
| R01AG078948 | Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration | 1 | 2025 |
| R01AI072435 | Characterization of Lamprey B cells and Antibodies | 1 | 2025 |
| R01AI118891 | Viral modulation of epitranscriptomic mechanisms | 1 | 2025 |
| R01AI125524 | Kinase Regulation of Nuclear Speckle Function and Splicing during Influenza Virus Infection | 1 | 2025 |
| R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 1 | 2025 |
| R01AI155962 | Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells | 1 | 2025 |
| R01AI157850 | Role of cellular long non-coding RNAs in HIV replication and disease outcome | 1 | 2025 |
| R01AR045203 | D4Z4 Coding Transcripts and FSHD | 1 | 2025 |
| R01AR049737 | Epidermal Signaling Regulators | 1 | 2025 |
| R01CA093729 | Repair of Genome Destabilizing DNA Structures | 1 | 2025 |
| R01CA096512 | Cell model for KSHV infection and genetic manipulation | 1 | 2025 |
| R01CA163217 | Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma | 1 | 2025 |
| R01CA186702 | Mechanisms of epitranscriptomic regulation in cancer | 1 | 2025 |
| R01CA200900 | Systemic RNA Delivery to Tumors | 1 | 2025 |
| R01CA205247 | Targeting MicroRNAs to Eradicate Leukemia Stem Cells | 1 | 2025 |
| R01CA207513 | Role of KLHL6 inactivation in mature B-cell malignancies | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3192/grants?page=7